Literature DB >> 11502828

Abnormal GH receptor signaling in children with idiopathic short stature.

M Salerno1, B Balestrieri, E Matrecano, A Officioso, R G Rosenfeld, S Di Maio, G Fimiani, M V Ursini, C Pignata.   

Abstract

Peripheral GH insensitivity may underlie idiopathic short stature in children. As the clinical and biochemical hallmarks of partial GH insensitivity have not yet been clearly elucidated, the identification of such patients is still difficult. We integrated functional, biochemical, and molecular studies to define the more reliable marker(s) of GH insensitivity. In particular, we measured GH receptor transducing properties through GH-induced protein tyrosine phosphorylation in patients' peripheral blood mononuclear cells and performed direct sequencing analysis of GH receptor-coding exons. Five of 14 idiopathic short stature patients with low basal IGF-I levels showed low or absent IGF-I increment after 4 d of GH administration. However, a prolonged GH stimulation induced in 3 of them an increase in IGF-I 40% above the baseline value. The IGF-binding protein-3 behavior paralleled that of IGF-I. The 2 GH-unresponsive subjects showed an abnormal tyrosine phosphorylation pattern after GH challenge. Sequence analysis of the GH receptor gene revealed a heterozygous mutation resulting in an Arg to Cys change (R161C) in exon 6 in only 1 patient, who had normal GH receptor responsiveness. Our findings indicate that abnormal GH receptor signaling may underlie idiopathic short stature even in the absence of GH receptor mutations. Thus, combining the 4-d IGF-I generation test and the analysis of GH-induced protein tyrosine phosphorylation is a useful tool to help identify idiopathic short stature patients with partial GH insensitivity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11502828     DOI: 10.1210/jcem.86.8.7759

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

Review 1.  Growth hormone and IGF-1.

Authors:  Roberto Salvatori
Journal:  Rev Endocr Metab Disord       Date:  2004-03       Impact factor: 6.514

Review 2.  Identification of the first patient with a confirmed mutation of the JAK-STAT system.

Authors:  Ron G Rosenfeld; Eric Kofoed; Caroline Buckway; Brian Little; Katie A Woods; Junko Tsubaki; Katherine A Pratt; Liliana Bezrodnik; Hector Jasper; Alejandro Tepper; Juan J Heinrich; Vivian Hwa
Journal:  Pediatr Nephrol       Date:  2005-02-02       Impact factor: 3.714

3.  Managing idiopathic short stature: role of somatropin (rDNA origin) for injection.

Authors:  J Paul Frindik; Stephen F Kemp
Journal:  Biologics       Date:  2010-06-24

4.  Growth hormone/insulin-like growth factor-1 axis as related to body mass index in patients with idiopathic short stature.

Authors:  Pinar Cengiz; Firdevs Bas; Fatmahan Atalar; Ahmet Ucar; Feyza Darendeliler; Gökce Akan; Tuğba Tarhan; Rüveyde Bundak
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013-02-19

Review 5.  Controversies in the definition and treatment of idiopathic short stature (ISS).

Authors:  Stefania Pedicelli; Emanuela Peschiaroli; Enrica Violi; Stefano Cianfarani
Journal:  J Clin Res Pediatr Endocrinol       Date:  2009-02-01

Review 6.  Emerging options in growth hormone therapy: an update.

Authors:  Stephen F Kemp; J Paul Frindik
Journal:  Drug Des Devel Ther       Date:  2011-08-30       Impact factor: 4.162

7.  Clinical Heterogeneity in two patients with Noonan-like Syndrome associated with the same SHOC2 mutation.

Authors:  Donatella Capalbo; Maria Giuseppa Scala; Daniela Melis; Giorgia Minopoli; Nicola Improda; Loredana Palamaro; Claudio Pignata; Mariacarolina Salerno
Journal:  Ital J Pediatr       Date:  2012-09-20       Impact factor: 2.638

8.  Effects of recombinant human growth hormone in the treatment of dwarfism and relationship between IGF-1, IGFBP-3 and thyroid hormone.

Authors:  Shanxiang Ren; Yuxiang Nie; Aihong Wang
Journal:  Exp Ther Med       Date:  2016-10-21       Impact factor: 2.447

9.  Baseline IGFBP - 3 as the Key Element to Predict Growth Response to Growth Hormone and IGF - 1 Therapy in Subjects with Non - GH Deficient Short Stature and IGF - 1 Deficiency.

Authors:  Sheila Perez-Colon; Oksana Lazareva; Radhika Purushothaman; Shahid Malik; Svetlana Ten; Amrit Bhangoo
Journal:  Int J Endocrinol Metab       Date:  2018-05-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.